American Cannabi Financials
This page shows American Cannabi (AMMJ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2023 annual data. Scores normalized against common benchmarks. How we calculate these scores
American Cannabi has an operating margin of -155.5%, meaning the company retains $-156 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -3.2% the prior year.
American Cannabi's revenue declined 86.8% year-over-year, from $18.8M to $2.5M. This contraction results in a growth score of 0/100.
American Cannabi has elevated debt relative to equity (D/E of 1824.21), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
American Cannabi's current ratio of 0.42 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While American Cannabi generated -$43K in operating cash flow, capex of $39K consumed most of it, leaving -$82K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
American Cannabi passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, American Cannabi generates $0.01 in operating cash flow (-$43K OCF vs -$3.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
American Cannabi earns $-33.9 in operating income for every $1 of interest expense (-$3.9M vs $114K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
American Cannabi generated $2.5M in revenue in fiscal year 2023. This represents a decrease of 86.8% from the prior year.
American Cannabi's EBITDA was -$3.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 574.0% from the prior year.
American Cannabi generated -$82K in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 72.9% from the prior year.
American Cannabi reported -$3.7M in net income in fiscal year 2023. This represents a decrease of 478.1% from the prior year.
American Cannabi held $21K in cash against $0 in long-term debt as of fiscal year 2023.
American Cannabi had 171M shares outstanding in fiscal year 2023. This represents an increase of 99.9% from the prior year.
American Cannabi's gross margin was 42.1% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 28.6 percentage points from the prior year.
American Cannabi's operating margin was -155.5% in fiscal year 2023, reflecting core business profitability. This is down 152.3 percentage points from the prior year.
American Cannabi's net profit margin was -147.8% in fiscal year 2023, showing the share of revenue converted to profit. This is down 144.4 percentage points from the prior year.
American Cannabi invested $39K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 62.3% from the prior year.
AMMJ Income Statement
| Metric | Q2'24 | Q1'24 | Q2'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $432K+68.9% | $256K-17.8% | $311K-48.1% | $600K-29.7% | $853K+19.7% | $712K-93.7% | $11.3M+433.1% | $2.1M |
| Cost of Revenue | $735K+389.9% | $150K | N/A | $164K-66.4% | $486K+11.6% | $436K-95.6% | $9.9M+428.4% | $1.9M |
| Gross Profit | -$303K-386.8% | $106K-29.7% | $150K-39.6% | $249K-32.1% | $366K+32.5% | $277K-81.2% | $1.5M+467.1% | $259K |
| R&D Expenses | N/A | $196 | N/A | $64K+29940.1% | $212-54.7% | $468 | N/A | $520 |
| SG&A Expenses | $249K+7.4% | $232K-0.5% | $233K-28.5% | $326K-25.5% | $438K-32.9% | $653K-26.0% | $882K+42.9% | $617K |
| Operating Income | -$557K-332.3% | -$129K+95.9% | -$3.1M-2333.9% | -$129K+2.3% | -$132K+70.0% | -$441K-178.0% | $565K+218.1% | -$478K |
| Interest Expense | $83K+1003.1% | $7K-90.4% | $78K+371.7% | -$29K-187.7% | $33K+3.5% | $32K+170.8% | -$45K-157.7% | $77K |
| Income Tax | N/A | $12K | N/A | N/A | N/A | N/A | N/A | $0 |
| Net Income | -$636K-379.9% | -$133K+95.6% | -$3.0M-1804.4% | -$157K-1426.9% | $12K+102.3% | -$522K-214.2% | $457K+215.0% | -$398K |
| EPS (Diluted) | $0.00 | N/A | N/A | $0.01 | $0.00 | N/A | $0.00 | $0.00 |
AMMJ Balance Sheet
| Metric | Q2'24 | Q1'24 | Q2'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1M-19.3% | $2.6M-7.1% | $2.8M-32.1% | $4.2M-6.3% | $4.5M+1.0% | $4.4M-4.5% | $4.6M+8.0% | $4.3M |
| Current Assets | $419K-48.7% | $818K-9.2% | $900K+12.1% | $803K-18.2% | $982K+14.1% | $861K-15.9% | $1.0M+8.5% | $943K |
| Cash & Equivalents | $3K-72.7% | $10K-52.4% | $21K+137.2% | $9K-90.4% | $93K+64.2% | $56K-51.9% | $118K-38.6% | $192K |
| Inventory | $266K-60.3% | $670K+14.3% | $586K+13.1% | $518K+2.0% | $508K+36.0% | $374K+5.9% | $353K+0.1% | $352K |
| Accounts Receivable | $137K+13.2% | $121K-48.5% | $234K+15.7% | $202K-31.0% | $293K-17.3% | $355K-24.4% | $469K+80.5% | $260K |
| Goodwill | N/A | N/A | N/A | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M-32.9% | $2.0M |
| Total Liabilities | $2.8M-0.1% | $2.8M-2.4% | $2.8M+0.9% | $2.8M-5.2% | $3.0M+1.1% | $2.9M+8.0% | $2.7M-10.1% | $3.0M |
| Current Liabilities | $2.2M+2.0% | $2.2M-0.6% | $2.2M+4.9% | $2.1M-4.7% | $2.2M-0.8% | $2.2M+4.1% | $2.1M-28.2% | $2.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$636K-385.5% | -$131K-8551.6% | $2K-99.9% | $1.3M-11.3% | $1.5M+0.8% | $1.5M-20.8% | $1.9M+48.7% | $1.3M |
| Retained Earnings | -$14.5M-4.6% | -$13.9M-1.0% | -$13.7M-28.9% | -$10.7M-1.2% | -$10.5M+0.1% | -$10.5M-4.6% | -$10.1M+4.3% | -$10.5M |
AMMJ Cash Flow Statement
| Metric | Q2'24 | Q1'24 | Q2'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $31K+372.6% | -$11K-103.9% | $288K+280.7% | -$159K-527.9% | $37K+117.8% | -$209K+22.1% | -$268K+53.7% | -$578K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$863+64.6% | -$2K-121850.0% | -$2 | $0+100.0% | -$9+100.0% | -$39K-435.8% | $12K+111.2% | -$104K |
| Financing Cash Flow | -$38K-15389.6% | $249+100.1% | -$246K-427.1% | $75K+8029.6% | -$950-100.5% | $187K+2.5% | $182K | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AMMJ Financial Ratios
| Metric | Q2'24 | Q1'24 | Q2'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -70.2%-111.5pp | 41.3%-7.0pp | 48.3%+6.8pp | 41.5%-1.5pp | 43.0%+4.2pp | 38.8%+25.8pp | 13.0%+0.8pp | 12.2% |
| Operating Margin | -128.9%-78.5pp | -50.4%+961.5pp | -1011.8%-990.3pp | -21.6%-6.0pp | -15.5%+46.3pp | -61.9%-66.9pp | 5.0%+27.5pp | -22.5% |
| Net Margin | -147.3%-95.5pp | -51.8%+910.0pp | -961.8%-935.6pp | -26.2%-27.6pp | 1.4%+74.7pp | -73.3%-77.3pp | 4.0%+22.8pp | -18.7% |
| Return on Equity | 16.8%+14.1pp | 2.7% | N/A | 14.1%+13.3pp | 0.8% | N/A | 24.5% | N/A |
| Return on Assets | -30.0%-24.9pp | -5.0%+100.8pp | -105.8%-102.0pp | -3.8%-4.0pp | 0.3%+12.1pp | -11.8%-21.8pp | 9.9%+19.2pp | -9.3% |
| Current Ratio | 0.19-0.2 | 0.38-0.0 | 0.42+0.0 | 0.39-0.1 | 0.45+0.1 | 0.39-0.1 | 0.49+0.2 | 0.32 |
| Debt-to-Equity | -4.34+16.7 | -21.06-1845.3 | 1824.21+1822.1 | 2.12+0.1 | 1.980.0 | 1.98+0.5 | 1.45-0.9 | 2.40 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.42), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is American Cannabi's annual revenue?
American Cannabi (AMMJ) reported $2.5M in total revenue for fiscal year 2023. This represents a -86.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is American Cannabi's revenue growing?
American Cannabi (AMMJ) revenue declined by 86.8% year-over-year, from $18.8M to $2.5M in fiscal year 2023.
Is American Cannabi profitable?
No, American Cannabi (AMMJ) reported a net income of -$3.7M in fiscal year 2023, with a net profit margin of -147.8%.
What is American Cannabi's EBITDA?
American Cannabi (AMMJ) had EBITDA of -$3.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
What is American Cannabi's gross margin?
American Cannabi (AMMJ) had a gross margin of 42.1% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is American Cannabi's operating margin?
American Cannabi (AMMJ) had an operating margin of -155.5% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.
What is American Cannabi's net profit margin?
American Cannabi (AMMJ) had a net profit margin of -147.8% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.
What is American Cannabi's free cash flow?
American Cannabi (AMMJ) generated -$82K in free cash flow during fiscal year 2023. This represents a 72.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is American Cannabi's operating cash flow?
American Cannabi (AMMJ) generated -$43K in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are American Cannabi's total assets?
American Cannabi (AMMJ) had $2.8M in total assets as of fiscal year 2023, including both current and long-term assets.
What are American Cannabi's capital expenditures?
American Cannabi (AMMJ) invested $39K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.
How many shares does American Cannabi have outstanding?
American Cannabi (AMMJ) had 171M shares outstanding as of fiscal year 2023.
What is American Cannabi's current ratio?
American Cannabi (AMMJ) had a current ratio of 0.42 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is American Cannabi's debt-to-equity ratio?
American Cannabi (AMMJ) had a debt-to-equity ratio of 1824.21 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is American Cannabi's return on assets (ROA)?
American Cannabi (AMMJ) had a return on assets of -129.4% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
What is American Cannabi's cash runway?
Based on fiscal year 2023 data, American Cannabi (AMMJ) had $21K in cash against an annual operating cash burn of $43K. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is American Cannabi's Piotroski F-Score?
American Cannabi (AMMJ) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are American Cannabi's earnings high quality?
American Cannabi (AMMJ) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can American Cannabi cover its interest payments?
American Cannabi (AMMJ) has an interest coverage ratio of -33.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is American Cannabi?
American Cannabi (AMMJ) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.